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ABSTRACT 
Analytical methods plays vital role in the process of identification, separation and then quantification of chemical components in natural 
materials or synthetic materials based on their chemistry. The main purpose of the analytical method development and validation is to prove 
that proposed analytical method is accurate, specific, precise and robust in the pharmaceutical industry for analysis of a drug moiety. Analytical 
method development gives important information in the pharmaceutical industry, on the potency of a drug, the drug’s bioavailability, the drug’s 
stability and also its effects. The analytical method validation is essential for analytical method development and tested for specificity, linearity, 
accuracy, precision, range, detection limit, quantitation limit and robustness. In summary, analytical method development and validation 
confirms that an accurate, precise and reliable potency measurement of a pharmaceutical preparation can be performed. 
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 It may be defined that Analytical chemistry is the study of 
separation, identification and quantification of chemical 
components of natural and artificial materials constituted 
with one or more compounds or elements. Analytical 
chemistry is divided into two main categories based on 
analysis, qualitative analysis that is to say the identification 
with regard to the chemical components exist in the sample, 
where as quantitative analysis estimates the numerical 
amount or concentration of certain element or compound 
present in the substance i.e., sample.  
Pharmaceutical analysis 1-3 plays a very outstanding role in 
the examination of pharmaceutical formulations and bulk 
drugs regarding the quality control and assurance. Number 
of drugs or compounds (New entities or partial structural 
modification of the existing one) introduced in the market, 
rapid increase in pharmaceutical industries 4, advancement 
in analytical instruments and production of drug around the 
world bring forward a rise in inevitable demand to seek 
novel and systematic analytical techniques in the 
pharmaceutical industries. The improvements of the 
analytical method development and analytical instruments 
have reduced the time and cost of analysis 5 and enhanced 
precision and accuracy. Techniques pertaining to analysis 
are developed and validated for active pharmaceutical 
ingredients, excipients, related substances, drug products, 
degradation products and residual solvents etc. Resulting 
which become an integral part of the required necessities for 
regulatory organization6. Analytical method development 
finally results in official test methods7. Consequently quality 
control laboratories used these methods to check the 
efficacy, identity, purity, safety as well as performance of 
products of the drug. Regulatory authorities give utmost 
importance on analytical methods in manufacturing. Drug 
approval by regulatory authorities requires the applicant to 
prove control of the entire process of drug development by 
using validated analytical methods 8.  
As there is a time lag from the date of introduction of a drug 
into the market to the date of its inclusion in 
pharmacopoeias, therefore it becomes necessary to develop 
novel analytical methods for such drugs. 
Modern pharmaceutical analysis needs the following key 
points 9 
1. Validation should address the performance of the 
analytical procedure under conditions of routine use. 
2. Suitability is strongly connected with both the 
requirements and the design of the individual analytical 
procedure, 
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3. Consequently, the analyst has to identify relevant 
parameters which reflect the routine performance of the 
given analytical procedure, to design the experimental 
studies accordingly and to define acceptance criteria for 
the results generated. 
4. Absolute, preferably normalised parameters should be 
selected as acceptance criteria. These can be defined 
from regulatory requirements, statistical considerations 
or experience. Statistical significance tests should be 
applied with caution; they do not take into 
consideration the practical relevance. 
5. Validation must not be regarded as a singular event. The 
analyst is responsible for the continued maintenance of 
the validated status of an analytical procedure. 
I) TYPICAL TECHNIQUES AND INSTRUMENTATION 
IN ANALYTICAL CHEMISTRY10 
The first instrumental analysis was flame emissive 
spectrometry developed by Robert Bunsen and Gustav 
Kirchhoff who discovered rubidium (Rb) and caesium (Cs) in 
186011.  
Currently there are many techniques and instrumentation 
available for qualitative and quantitative determination of 
drugs based on their physical (solubility, transparency or 
degree of turbidity, color, density or specific gravity for 
liquids, melting, freezing, boiling points and moisture 
content) chemical, physicochemical 12,13(physical 
phenomena that happened as a result of chemical reactions). 
Some of the techniques are mentioned below: 
1. Titrimetric techniques  
2. Chromatographic techniques   
3. Spectroscopic techniques  
4. Electrochemical methods  
5. Kinetic method of analysis  
6. Electrophoretic methods  
7. Flow injection and sequential injection analysis  
8. Hyphenated techniques 
1. Titrimetric techniques: 
Origin of the titrimetric method of analysis goes back to 
somewhere in the middle of the 18th century. It was the year 
1835 when Gay–Lussac invented the volumetric method 
which subsequently leads to the origin of term titration. 
Although the assay method is very old yet there are signs of 
some modernization, i.e., spreading of non-aqueous titration 
method, expanding the field of application of titrimetric 
methods to (very) weak acids and bases as well as 
potentiometric end point detection improving the precision 
of the methods. With the development of functional group 
analysis procedures titrimetric methods have been shown to 
be beneficial in kinetic measurements which are in turn 
applied to establish reaction rates. There are many 
advantages associated with these methods which include 
saving time and labour, high precision and the fact that there 
is no need of using reference standards. 
2. Chromatographic techniques: 
The objective of chromatography is to separate the various 
substances that make up a mixture. The applications range 
from a simple verification of the purity of a given compound 
to the quantitative determination of the components of a 
mixture. The chromatographic system consists of a fixed 
phase and a moving phase. The mixture to be analyzed or 
solute is introduced into the system through the mobile 
phase, and it is the affinity of the solute for one phase over 
the other which governs its separation from the other 
components. Each component is retained to a different 
degree in the system and retention is based on various 
attraction forces. A chromatogram is a graphical 
representation of the compounds eluting from a 
chromatographic system. Chromatography can be used for 
qualitative and quantitative determination of various food 
constituents. Paper chromatography, Thin layer 
chromatography14, Gas liquid chromatography15, High 
performance liquid chromatography 16,17 are the available 
choices for assay involving sophisticated equipment, which 
are highly sensitive, accurate and consume very tiny amount 
of samples for analysis. 
3. Spectroscopic techniques: 
3.1 Spectrophotometry: 
Another important group of methods which find an 
important place in pharmacopoeias are spectrophotometric 
methods based on natural UV absorption and chemical 
reactions. Spectrophotometry is the quantitative 
measurement of the reflection or transmission properties of 
a material as a function of wavelength. 
The advantages of these methods are low time and labour 
consumption. The precision of these methods is also 
excellent. The use of UV–Vis spectrophotometry especially 
applied in the analysis of pharmaceutical dosage form has 
increased rapidly over the last few years. The colorimetric 
methods are usually based on the following aspects: 
 Complex-formation reaction 
 Oxidation-reduction process 
 A catalytic effect 
3.2 Near infrared spectroscopy (NIRS) 
Near infrared spectroscopy (NIRS) is a rapid and non-
destructive procedure that provides multi component 
analysis of almost any matrix. In recent years, NIR 
spectroscopy has gained a wide appreciation within the 
pharmaceutical industry for raw material testing, product 
quality control and process monitoring. The growing 
pharmaceutical interest in NIR spectroscopy is probably a 
direct consequence of its major advantages over other 
analytical techniques, namely, an easy sample preparation 
without any pre-treatments, the probability of separating the 
sample measurement position by use of fibre optic probes, 
and the expectation of chemical and physical sample 
parameters from one single spectrum. The major 
pharmacopoeias have generally adopted NIR techniques. 
3.3 Nuclear magnetic resonance spectroscopy (NMR) 
Since the first report appeared in 1996 describing the use of 
NMR spectroscopy to screen for the drug molecules, the field 
of NMR based screening has proceeded promptly. Over the 
last few years, a variety of state-of-the art approaches have 
been presented and found a widespread application in both 
pharmaceutical and academic research. Recently NMR finds 
its application in quantitative analysis in order to determine 
the impurity of the drug, characterization of the composition 
of the drug products and in quantitation of drugs in 
pharmaceutical formulations and biological fluids. 
3.4 Fluorimetry and phosphorimetry 
The pharmaceutical industries continuously look for the 
sensitive analytical techniques using the micro samples. 
Fluorescence spectrometry is one of the techniques that 
serve the purpose of high sensitivity without the loss of 
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specificity or precision.  A gradual increase in the number of 
articles on the application of fluorimetry and 
phosphorimetry in quantitative analysis of various drugs in 
dosage forms and biological fluids has been noticed in the 
recent past. 
4. Electroanalytical techniques or methods: 
Electrochemistry is the relationship between electrical 
properties and chemical substances in reactions. In its 
application to analytical chemistry, this generally involves 
the measurement of some electrical property under 
conditions which, directly or indirectly, allow an association 
between the magnitude of the property measured and the 
concentration of some particular chemical species. Both 
direct potentiometry and the potentiometric titration 
method require the measurement of emf between an 
indicator electrode system and a reference electrode system, 
the two comprising a cell system. In many present-day 
applications, the indicator and the reference electrodes are 
combined in a single electrode system called a “combination 
electrode. The application of electrochemical techniques in 
the analysis of drugs and pharmaceuticals has increased 
greatly over the last few years. The renewed interest in 
electrochemical techniques can be attributed in part to more 
sophisticated instrumentation and to increase the 
understanding of the technique themselves. 
5. Kinetic methods of analysis 
Kinetic method of analysis has been developing since 1950s 
and yet in modern days it is taking a major resurgence in 
activity. The repetitive interest in the kinetic methods can be 
credited to the advancements made in principles, in 
automated instrumentation, in understanding the chemical 
and instrumentation, in data analysis methods and in the 
analytical application. From the literature it is evident that 
the kinetic approach to analytical chemistry is rather general 
with several advantages over traditional equilibrium 
approach. Essentially, kinetic methods trust the 
measurements of concentration changes (detected via signal 
changes) in a reactant (which may be the analyte itself) with 
time after the sample and reagents have been mixed 
manually or mechanically. 
6. Electrophoretic methods 
Another important instrument essential for the analysis of 
pharmaceuticals is capillary electrophoresis (CE). CE is a 
relatively new analytical technique based on the separation 
of charged analytes through a small capillary under the 
impact of an electric field. In this technique solutes are 
perceived as peaks as they pass through the detector and the 
area of individual peak is proportional to their 
concentration, which allows quantitative estimations.  
7. Flow injection and sequential injection analysis 
The basis of Flow injection analysis (FIA) is injection of a 
liquid sample into a moving, non-segmented uninterrupted 
carrier stream of a suitable liquid. The injected sample forms 
a zone, which is then transported toward a detector that 
uninterruptedly records the changes in absorbance, 
electrode potential, or other physical parameter resulting 
from the passage of the sample material through the flow 
cell. The stages of flow injection analysis have been shown in 
Fig. 1. 
 
Figure 1: Stages of flow injection analysis. Source: 
http://ww2.chemistry.gatech/edu/class/analyst/fia/pdf
. 
8. Hyphenated techniques 
The coupling of a separation technique and on-line 
separation technique leads to the development of a 
hyphenated technique. The last two decades saw a 
remarkable advancement in the hyphenated techniques and 
its application in pharmaceutical analysis. A variety of 
hyphenated techniques such as LC-MS, GC-MS, LC-NMR, CE-
ICP-MS and CE-MS have been applied in the analysis of 
pharmaceuticals.  
II) ANALYTICAL METHOD DEVELOPENT18-21 
When there are no compendial methods are available, new 
methods are being developed for analysis of novel products. 
To analyze the existing either pharmacopoeial or non-
pharmacopoeial products novel methods are developed to 
reduce the cost besides time for better precision and 
ruggedness. These methods are optimized and validated 
through trial runs. Alternate methods are proposed and put 
into practice to replace the existing procedure in the 
comparative laboratory data with all available merits and 
demerits.  
Regulatory perspectives on development of novel 
methods of drug analysis are:  
a) When there is no official drug or drug combination 
available in the pharmacopoeias.  
b) When there is no validated analytical process for the 
existing drug in the literature due to patent regulations.  
c) When there are no analytical methods for the formulation 
of the drug due to the interference caused by the formulation 
excipients. 
 d) Analytical methods for the quantitation of the analyte in 
biological fluids are found to be unavailable.  
Steps for analytical method development: 
The procedure for analytical method development follows a 
set of steps as below:  
1. Purpose of Analytical Method Development: 
 In the pharmaceutical industry, analytical method 
development gives important information on the potency of 
a drug, the drug’s bioavailability, the drug’s stability and also 
its effects. In the very first step, the purpose of conducting 
any analytical method development is established. 
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2. Highlighting of Steps 
 In the second step of Analytical Method Development, the 
steps involved in the development are recorded in a 
laboratory book or online database. 
3. Characterization of the Analyte  
In this step, both the biological and chemical properties in 
addition to the physical properties of the analyte are 
collected. After that, the analyte is obtained and stored 
according to its specific requirements. The methods for 
analysis are then recorded with an example being the 
chromatography technique which employs different 
methods such as the High Performance Liquid 
Chromatography.  
4. Arrangement and definition of Requirements  
5. Requirements for the method development of the 
analysis are done and recorded. All the materials, 
reagents and instruments are procured those are 
required for the analysis of the sample.  
6.  Review of Literature and existing Methods  
All literature information related to the specific analyte e.g. a 
specific drug is assessed for any biological, chemical and 
chemical properties regarding the analyte. Reference is then 
taken from journals, books and any other publications.  
7.  Choosing an Analytical Method  
From the information obtained from the literature during the 
literature review, a specific methodology is modified to cater 
for accurate output and also because methods change with 
the requirements of the analyte. If there are no previous 
methods in the literature being reviewed regarding the 
analyte, the procedure goes on uninterrupted.  
8. Setting up of Instruments  
Appropriate instruments for the analytical method 
development are set up in the laboratory by each of the 
instruments standard operating procedures. Standard 
Operating Procedures usually abbreviated as SOP's are a set 
of instructions or steps to aid in performing a specific 
procedure in a laboratory set up. They are usually universal 
and standardized for ease of use in any laboratory set up.  
9. Optimization of the Method  
In carrying out the optimization of the analytical method, 
parameters are changed individually depending on the 
arising interests. Optimization of an analytical method is 
done in reference to a systematic and procedural plan while 
making sure to critically follow all the documented steps.  
10. Analytical Figures of Merit Documentation  
Documentation of the analytical figures of merit decided 
upon is done. These analytical figures of merit include 
quantification limits, detection limits, analysis time frame, 
operational costs and sample preparation.  
11. Development Method Evaluation  
The resultant product of analysis should give a desirable 
result as expected in the identification of the analyte.  
12. Sample Estimation, Quantitative Demonstration and 
Analysis of Samples  
Estimation of an analyte with an example being a drug in a 
matrix sample containing the analyte is done here.  
III) ANALYTICAL METHOD VALIDATION 22-26 
The objective of validation of an analytical procedure is to 
demonstrate that it is suitable for its intended purpose. 
Guidelines from the USP, ICH, US-FDA etc., can provide a 
framework for validations of pharmaceutical methods. 
Results from the method validation can be considered to 
judge its quality, reliability as well consistency pertaining to 
analytical results. 
Types of Analytical Procedures to be validated  
The discussion of the validation of analytical procedures is 
directed to the four most common types of analytical 
procedures:  
- Identification tests;  
- Quantitative tests for impurities' content;  
- Limit tests for the control of impurities;  
- Quantitative tests of the active moiety in samples of drug 
substance or drug product or other selected component(s) in 
the drug product. 
Parameters of Analytical Method Validation  
Analytical methods have been validated in pursuance of ICH 
guidelines of Q2 (R1). Validation parameters are:  
1. System suitability 
2. Specificity  
3.  Linearity  
4. Precision  
5. Accuracy  
6. LOD  
7. LOQ 
8. Robustness 
As a regulatory perspective, minimum numbers of 
determinations along with different types of test are 
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Common method validation issues from regulatory 
perspective are: 
 Wide validation acceptance criteria that is not well 
justified 
 Incomplete system suitability criteria 
 Inappropriate method controls 
 Linearity assessed using serial dilution 
 No product/assay control sample in bioassay 
 Plate effects not evaluated 
 LOQ is not within the validated linear range 
 Specification does not fall within the validated linear 
range  
 Validation conditions/equipment are different than the 
method validation SOP 
 Method is validated for purity but not impurities 
 Specificity does not include other products 
manufactured at the same site 
 Stressed samples not used for validation of impurity 
detection 
 Impurities levels detected below the LOQ reported 
numerically 
 Method fails robustness evaluation and parameters not 
reflected in the method SOP 




This review article provides a structured way to perform 
method validation as per regulatory perspective for its 
intended purpose and to assure the capabilities of the test 
method. Although the requirements of validation have been 
clearly documented by regulatory authorities, the approach 
to validation is varied and opened to interpretation, and 
validation requirements differ during the development 
process of pharmaceuticals. Validation is an important 
procedure in the pharmaceutical industry and it is utilized to 
ensure that quality is built into the processes by following 
CGMP and standard procedures. 
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